Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -228,000 | -164,385 | -76,705 | -293,654 | -227,479 |
| Depreciation Amortization | 4,401 | 3,862 | 2,276 | 12,223 | 9,756 |
| Accounts receivable | -16,283 | -10,007 | -1,299 | 765 | 983 |
| Accounts payable and accrued liabilities | -14,057 | -20,784 | 40,473 | 5,909 | -5,120 |
| Other Working Capital | -146,348 | -111,773 | -45,999 | 70,430 | 76,217 |
| Other Operating Activity | 103,587 | 90,925 | -20,337 | 58,394 | 52,223 |
| Operating Cash Flow | $-296,700 | $-212,162 | $-101,591 | $-145,933 | $-93,420 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -155,480 | -102,813 | -742 | -156,641 | -89,919 |
| PPE Investments | -2,268 | -1,584 | N/A | -3,735 | -3,400 |
| Net Acquisitions | N/A | 656 | -591 | N/A | N/A |
| Sale Of Investment | 300,507 | 192,938 | 104,815 | 284,492 | 216,342 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -35,000 | -35,000 |
| Other Investing Activity | 656 | 0 | 0 | -35,000 | -35,000 |
| Investing Cash Flow | $143,415 | $89,197 | $103,482 | $89,116 | $88,023 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 74,078 | 74,078 | N/A | N/A | 0 |
| Debt Repayment | -430 | -408 | -172 | -538 | -325 |
| Common Stock Issued | 52,093 | 52,093 | 31,657 | 4,184 | 2,989 |
| Other Financing Activity | -2,746 | -2,746 | 0 | 43,130 | -4,562 |
| Financing Cash Flow | $122,995 | $123,017 | $31,485 | $46,776 | $-1,898 |
| Exchange Rate Effect | -4,496 | -3,167 | -526 | -5,482 | -7,968 |
| Beginning Cash Position | 155,700 | 155,700 | 155,700 | 171,223 | 171,223 |
| End Cash Position | 120,914 | 152,585 | 188,550 | 155,700 | 155,960 |
| Net Cash Flow | $-34,786 | $-3,115 | $32,850 | $-15,523 | $-15,263 |
| Free Cash Flow | |||||
| Operating Cash Flow | -296,700 | -212,162 | -101,591 | -145,933 | -93,420 |
| Capital Expenditure | -2,268 | -1,584 | N/A | -3,741 | -3,408 |
| Free Cash Flow | -298,968 | -213,746 | -101,591 | -149,674 | -96,828 |